Mindy Waizer

Social Habits, Cancer Type and Treatment Impact Increased Rates of Opioid Use

November 26, 2018

Patients who received chemotherapy, actively smoked and drank alcohol, and were diagnosed with head and neck cancer reported significantly higher rates of opiate use, according to study results presented at the American Society of Clinical Oncology (ASCO) 2018 Palliative and Supportive Care Symposium.

Teen Cancer Awareness All Year Round

January 20, 2018

The third week in January is national Teen Cancer Awareness Week, a time to shine light on the unique medical, emotional and psychosocial needs of teens with cancer. But one organization focuses on these concerns year-round: Teen Cancer America (TCA).

Patient Advocates Learn from Each Other

December 06, 2017

Key takeaways from the National Comprehensive Cancer Network® (NCCN)’s Patient Advocacy Summit reveal progress made toward improving survivorship care and planning, and identify opportunities for improvement.

What Comes Next for Cancer Survivors?

December 04, 2017

At the National Comprehensive Cancer Network® (NCCN)’s Patient Advocacy Summit – a meeting designed to share best practices for survivorship planning care among advocacy organizations – Yelak Biru shared his story of survivorship, and how he has been able to integrate multiple myeloma into his life for more than two decades.

Don't Claim Marijuana Products Cure Cancer, FDA Warns

November 02, 2017

Four companies drew the ire of the Food and Drug Administration this week for claiming that their marijuana-derived products can treat or cure cancer. The agency issued letters of warning, and threatened punitive action if the companies do not correct the violations.

Older Adults with AML Don't Understand the Risks and Likely Outcomes of Treatment

October 24, 2017

Older patients with acute myeloid leukemia (AML) often face a difficult choice: risky, intensive chemotherapy that offers a small chance of a cure versus non-intensive chemotherapy meant to improve physical comfort and quality of life.

Patient Advocacy Contributes to Progress in Multiple Myeloma Treatment

September 14, 2017

David S. Siegel, M.D., Ph.D., chief of the division of Multiple Myeloma at the John Theurer Cancer Center, attributes some of the progress in myeloma treatment to patients and how they advocate for themselves.